New! Sign up for our free email newsletter.
Science News
from research organizations

Controlling asymmetry for drug synthesis

Iridium-catalyzed hydrogen addition, giving plant- and insect-based natural substances

Date:
July 27, 2021
Source:
Wiley
Summary:
The cost-effectiveness of drug synthesis depends on a number of factors, including the amount of waste produced. A team of researchers have now discovered a catalyst that achieves exceptionally high-precision addition of hydrogen to carbon-carbon bonds, improving targeted synthesis by avoiding convoluted multi-step processes, and reducing wasteful by-products. The authors herald the reaction as especially useful in the production of complex natural substances such as pheromones.
Share:
FULL STORY

The cost-effectiveness of drug synthesis depends on a number of factors, including the amount of waste produced. A team of researchers have now discovered a catalyst that achieves exceptionally high-precision addition of hydrogen to carbon-carbon bonds, improving targeted synthesis by avoiding convoluted multi-step processes, and reducing wasteful by-products. In the journal Angewandte Chemie, the authors herald the reaction as especially useful in the production of complex natural substances such as pheromones.

The natural world contains a vast array of natural products, many of which have also become indispensable drugs for humans. For example, plant-based natural substances such as polyketides and pheromones have significant potential as antitumor drugs and antibiotics. However, many of these pharmaceutically active substances are only effective in one of their two possible configurations, akin to mirror images of each other, and may even be harmful in the other form.

To ensure that the right substance is produced, synthetic chemists generally have no choice but to be wasteful: either by using convoluted processes or performing a number of different steps. For example, they might synthesize both forms of a compound, then have to eliminate the unwanted one, or they might use a specific, but potentially expensive, catalyst to only produce the form of interest.

Pher G. Andersson and his team from Stockholm University, Sweden, have now discovered that a catalyst made of the heavy metal iridium and organic phosphorus-nitrogen units is exceptionally good at hydrogenating symmetrical organic compounds. The ensuing reaction is not only highly economical, with no by-products formed, but also particularly important for drug synthesis since the configuration -- that is, the handedness of the product -- is decided at the time of hydrogenation.

Simple, symmetrical unsaturated bonds are suitable as precursors for the synthesis of polyketides and pheromone-derived natural products. The team's iridium catalyst now makes it possible to hydrogenate one of the symmetrical carbon-carbon bonds in a targeted way: "This method represents the first example of iridium-catalyzed hydrogenative desymmetrization of dienes," the authors say. They demonstrated just how useful their new method could be using dozens of precursor substances that they converted to the desired products. In every case, virtually no by-products were formed.

The target configuration at the oxygen group near an unsaturated bond was decisive in the success of this approach. Many pheromones or polyketides contain the so-called allyl carbinols with this oxygen-carbon arrangement, while others contain nitrogen groups and are referred to as allyl carbamines. Regardless of whether the iridium catalyst was used on nitrogen or oxygen, it gave the correct end configuration. Another common structural motif in natural substances is the lactones. Even confronted with this structure, the iridium catalyst performed well and the researchers were able to find a simple synthesis route by hydrogenative desymmetrization.

The authors also used the new method to carry out formal total synthesis of two natural substances: firstly, zaragozic acid, a polyketide obtained from fungi, and secondly, invictolide, an ant pheromone. The authors are confident that, because of the high level of selectivity and the virtually total preference for one configuration, giving the product with the correct handedness, the method is an economical and versatile alternative for synthesizing many pharmaceutical products.


Story Source:

Materials provided by Wiley. Note: Content may be edited for style and length.


Journal Reference:

  1. Haibo Wu, Hao Su, Erik J. Schulze, Bram B. C. Peters, Mark D. Nolan, Jianping Yang, Thishana Singh, Mårten S. G. Ahlquist, Pher G. Andersson. Site‐ and Enantioselective Iridium‐Catalyzed Desymmetric Mono‐Hydrogenation of 1,4‐Dienes. Angewandte Chemie International Edition, 2021; DOI: 10.1002/anie.202107267

Cite This Page:

Wiley. "Controlling asymmetry for drug synthesis." ScienceDaily. ScienceDaily, 27 July 2021. <www.sciencedaily.com/releases/2021/07/210727145231.htm>.
Wiley. (2021, July 27). Controlling asymmetry for drug synthesis. ScienceDaily. Retrieved February 21, 2024 from www.sciencedaily.com/releases/2021/07/210727145231.htm
Wiley. "Controlling asymmetry for drug synthesis." ScienceDaily. www.sciencedaily.com/releases/2021/07/210727145231.htm (accessed February 21, 2024).

Explore More
from ScienceDaily

RELATED STORIES